CN Patent

CN115590831A — 一种富马酸二甲酯缓释微片及其制备方法

Assigned to Lipin Pharmaceutical Xiamen Co ltd · Expires 2023-01-13 · 3y expired

What this patent protects

本发明提供一种富马酸二甲酯缓释微片及其制备方法，将富马酸二甲酯、润滑剂及助流剂投入混合机混合后，以微型片冲头直接压制即得。该缓释微片无需加入缓释基质材料即可达到24h缓释效果，且其缓释效果不易受机械压力的影响，剂量倾泻风险小，可减少胃肠道刺激等不良反应。

USPTO Abstract

本发明提供一种富马酸二甲酯缓释微片及其制备方法，将富马酸二甲酯、润滑剂及助流剂投入混合机混合后，以微型片冲头直接压制即得。该缓释微片无需加入缓释基质材料即可达到24h缓释效果，且其缓释效果不易受机械压力的影响，剂量倾泻风险小，可减少胃肠道刺激等不良反应。

Drugs covered by this patent

Patent Metadata

Patent number: CN115590831A
Jurisdiction: CN
Classification: —
Expires: 2023-01-13
Drug substance claim: No
Drug product claim: No
Assignee: Lipin Pharmaceutical Xiamen Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.